ClinicalTrials.Veeva

Menu

Role of Ultrasound in Diagnosis of Placenta Previa and MAP

A

Aljazeera Hospital

Status

Completed

Conditions

Morbidly Adherent Placenta

Study type

Observational

Funder types

Other

Identifiers

NCT03416296
placenta

Details and patient eligibility

About

Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.

Full description

The most accepted theory is that abnormal placentation . The most important risk factor for placenta accreta is placenta previa after a prior cesarean delivery. The first clinical manifestation of placenta accreta is usually severe , life-threatening hemorrhage. The recommended intervention of suspected placenta accreta is planned preterm cesarean hysterectomy with the placenta left in situ.

Enrollment

90 patients

Sex

Female

Ages

20 to 43 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • pregnant ladies with previous cesarean sections
  • GA above 30 weeks

Exclusion criteria

  • Primigravida patients
  • GA below 30 weeks

Trial design

90 participants in 2 patient groups

normal placenta
Description:
TA , TV ,TP us
placenta previa and MAP
Description:
TA,TV.TP us

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems